Total Payments
$6,553
2024 Payments
$891.22
Companies
67
Transactions
313
Medicare Patients
205
Medicare Billing
$13,473
Payment Breakdown by Category
Food & Beverage$6,155 (93.9%)
Research$150.00 (2.3%)
Consulting$125.00 (1.9%)
Education$122.89 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,155 | 305 | 93.9% |
| Unspecified | $150.00 | 1 | 2.3% |
| Consulting Fee | $125.00 | 1 | 1.9% |
| Education | $122.89 | 6 | 1.9% |
Payments by Type
General
$6,403
312 transactions
Research
$150.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $729.28 | 24 | $0 (2024) |
| Foundation Medicine, Inc. | $501.80 | 12 | $0 (2019) |
| Gilead Sciences, Inc. | $434.73 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $308.54 | 13 | $0 (2024) |
| Alkermes, Inc. | $307.30 | 15 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $286.22 | 17 | $0 (2024) |
| Lilly USA, LLC | $254.89 | 14 | $0 (2024) |
| Clovis Oncology, Inc. | $195.54 | 10 | $0 (2021) |
| Kyowa Kirin, Inc. | $169.43 | 11 | $0 (2020) |
| ABBVIE INC. | $166.80 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $891.22 | 42 | Indivior Inc. ($162.93) |
| 2023 | $614.41 | 29 | AbbVie Inc. ($102.47) |
| 2022 | $934.95 | 45 | US Oncology Corporate, Inc. ($127.71) |
| 2021 | $595.00 | 33 | Gilead Sciences, Inc. ($123.80) |
| 2020 | $584.01 | 28 | Indivior Inc. ($150.00) |
| 2019 | $999.80 | 56 | Alkermes, Inc. ($128.14) |
| 2018 | $1,048 | 46 | Foundation Medicine, Inc. ($284.56) |
| 2017 | $885.14 | 34 | Foundation Medicine, Inc. ($202.95) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: OUD | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.13 | General |
| 11/20/2024 | Day One Biopharmaceuticals | OJEMDA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: OUD | ||||||
| 11/07/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: NONE | ||||||
| 11/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: HIV | ||||||
| 10/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: HIV | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PAIN | ||||||
| 10/11/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: OUD | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.51 | General |
| 09/13/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Opioid Use Disorder | ||||||
| 09/11/2024 | Tempus AI, Inc | Tempus Pixel (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Radiology | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.79 | General |
| 08/22/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Oncology | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: NONE | ||||||
| 07/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: OUD | ||||||
| 06/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information | Indivior Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 63 | 108 | $19,032 | $4,404 |
| 2021 | 4 | 77 | 104 | $20,075 | $4,815 |
| 2020 | 4 | 65 | 98 | $18,013 | $4,255 |
Total Patients
205
Total Services
310
Medicare Billing
$13,473
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 27 | $8,470 | $2,406 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 45 | $9,842 | $1,892 | 19.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 25 | 36 | $720.00 | $106.62 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 21 | $6,710 | $1,918 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 29 | $6,316 | $1,438 | 22.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,228 | $1,335 | 21.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 29 | 41 | $820.00 | $123.00 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 26 | $8,140 | $2,152 | 26.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $5,387 | $1,221 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 17 | $3,626 | $753.29 | 20.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 27 | 43 | $860.00 | $128.58 | 15.0% |
About Dr. Gregory Burzynski, MD
Dr. Gregory Burzynski, MD is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952592131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Burzynski, MD has received a total of $6,553 in payments from pharmaceutical and medical device companies, with $891.22 received in 2024. These payments were reported across 313 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($6,155).
As a Medicare-enrolled provider, Burzynski has provided services to 205 Medicare beneficiaries, totaling 310 services with total Medicare billing of $13,473. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Houston, TX
- Active Since 08/05/2007
- Last Updated 01/21/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952592131
Products in Payments
- FOUNDATIONONE (Device) $501.80
- SUBLOCADE (Drug) $432.06
- OPDIVO (Biological) $202.27
- Vivitrol 380 mg (Drug) $179.16
- Rubraca (Drug) $172.52
- NURTEC ODT (Drug) $163.65
- VRAYLAR (Drug) $159.69
- BUPRENORPHINE AND NALOXONE (Drug) $150.00
- APRETUDE (Biological) $149.15
- SUBOXONE SUBLINGUAL FILM (Drug) $147.22
- Lucemyra/Lofexidine (Drug) $134.19
- MOUNJARO (Drug) $134.18
- Dayvigo (Drug) $126.79
- Seglentis (Drug) $114.17
- GRANIX (Drug) $112.49
- GILOTRIF (Drug) $110.64
- Senza Spinal Cord Stimulation System (Device) $110.61
- VIVITROL (Drug) $110.14
- SANCUSO (Drug) $108.75
- ERLEADA (Drug) $108.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947